#USA#BreakingNews#News
A sign for biotechnology company, Biogen, Inc. is seen on a building in Cambridge, Massachusetts, on March 18, 2017. Biogen’s ALS treatment is the first approved treatment to target a genetic cause of ALS. (DOMINICK REUTER/AFP via Getty Images)Biogen has gotten the green light for a breakthrough ALS treatment that targets a devastating, ultra-rare genetic form of the progressive neurodegenerative disease.
Originally published at Rick Sobey